AllDocs -> cancers

1 Introduction 1.1 Liver cancer 1.1.1 Hepatocellular carcinoma Hepatocellular carcinoma (HCC) accounts for more than 90% of all primary liver cancers (Yu A. S. & Keeffe E. B., 2003). It ranks fifth in frequency worldwide among all malignancies and causes one million deaths annually (Qian J. et al., 2003; Yu A. S. & Keeffe E. B., 2003). Over 500,000 new cases are currently diagnosed every year (Llovet J. M. et al., 2003) and HCC affects about three folds more males than females (Perry J. F. et al., 2003). The incidence of HCC in Northern Europe, Australia and Caucasian populations in North America is less than 3 cases per 100,000 men, while the number of cases in Eastern Asia, Middle and Western Africa is much higher, and ranges from 20.8 to 48 per 100,000 individuals, since hepatitis B is endemic to those regions (Bosch F. X. et al., 1999). However, in the United States, owing to ...

11 1 Department of Medical Oncology 2 Department of Surgery Hospital de Fuenlabrada Fuenlabrada (Madrid) España Recibido: 16.07.2005 Aceptado: 19.07.2005 Review Liver metastases of colon cancer . New therapeutic approaches. Neoadjuvant chemotherapy A. Ruiz-Casado 1 , F. Pereira 2 Summary Colon cancer witnesses one of most exciting and evolving times in the latest years. About 30% of patients with isolated liver colon metastases can now be cured through a multidisciplinary approach of the disease. New systemic treatments have moved the median survival of metastatic disease from 12 months four years ago to 20 months and beyond. Incorporation of new biologic treatments into the neoadjuvant setting may help to further improve historical outcomes and offers promise to continue this trend. Appropriate surrogate ...

Liver metastases are the major cause of death in patients with colorectal cancer . Surgical resection is now recognised as the most effective treatment for liver metastases resulting from colorectal cancer and from a high proportion of other primary tumours. The ability to resect disease is associated with 5-year survival rates of 30-50% 1, 2 . Generally the surge- on is faced with two different situations as outlined below: Primarily Resectable metastases Only a minority of patients with liver metastases (10-20 percent) are initially candidates for potentially curative resec- tion. For those who do undergo surgery, prognostic factors of recurrence are well known and include mainly the number and size of metastases, the presence of extra-hepatic disease, the degree of invasion of the primary tumour and for some se- ries the synchronous or metachronous pattern of the metasta- ...

The 1996-2000 average annual age-adjusted incidence rate for invasive cancers of the liver and intrahepatic bile duct was almost three times higher in males than in females (6.8 compared to 2.4 per 100,000), and blacks of both sexes had higher rates compared to whites. There were 708 cases of liver /intrahepatic bile duct cancers diagnosed and reported among residents of Pennsylvania for 2000 – the highest annual figure recorded between 1991 and 2000. The annual age-adjusted incidence rates by sex and race for ten years (1991 through 2000) showed increasing rates among males, especially black males, and females of both races. The 1996-2000 average annual age-specific incidence rates show that black males have had the highest risks. During the period of 1996-2000, over 62 percent of the cases were diagnosed among residents 65 years of age or older. In 2000, over 57 percent of the staged liver /intrahepatic bile duct cancers were diagnosed ...

Liver cancer The liver is the largest organ inside the body. It is located on the right hand side of the abdomen and is protected by the ribcage. Its functions include: • Destroying harmful substances, such as alcohol, and getting rid of waste products. • Converting food containing fats and sugars to be used by the body for energy. • Producing bile to help the digestion of food. The liver will function normally with only a small portion of it in working order. Liver cancer can be a primary cancer (starts in the liver) or a secondary cancer (starts in another part of the body and spreads to the liver). Primary liver cancers Primary liver cancer is one of the less common cancers in Victoria with about 230 people diagnosed each year. It is more common in men and people aged over 60 years. Most primary liver cancers start in lever cells ...

Liver cancer Liver cancer can be a primary cancer (starts in the liver ) or a secondary cancer (starts in another part of the body and spreads to the liver ). Primary liver cancer is one of the less common cancers in Victoria. Secondary liver cancers are the most common liver cancers. Liver cancer usually has no symptoms in the early stages. Functions of the liver The liver is the largest organ inside the body. It is located on the right hand side of the abdomen and is protected by the ribcage. The liver will function normally with only a small portion of it in working order. Its functions include: • Destroying harmful substances, such as alcohol, and getting rid of waste products. • Converting food containing fats and sugars to be used by the body for energy. • Producing bile to help the digestion of food. ...

A BASIC INFORMATION DESCRIPTION Uncontrolled growth of malignant cells in the liver. Liver cancer may be primarily resulting from abnormal liver or bile-duct cells, or it may result from spread of cancer from another site (metastases). The most com- mon sources are cancers of the rectum, colon, lung, breast, pancreas, esophagus or skin (malignant melanoma). Liver cancer can affect all ages, but is most common in men over 60. FREQUENT SIGNS AND SYMPTOMS • Loss of appetite and weight loss. • Tender mass in the right upper abdomen. • Pain in the upper abdomen. • Low fever, usually less than 101°F (38.3°C). • Yellow eyes and skin (sometimes). • Swollen abdomen from fluid retention (sometimes). • Lethargy. CAUSES Unknown. It occurs most often in population groups with a high incidence of viral hepatitis and other chronic liver diseases. RISK INCREASES ...

A204: Liver cancer tissues - Hepatocellular carcinoma (formalin fixed) For research use only Specifications: •No. of cases: 35 •Tissue type: Liver cancer tissues – Hepatocellular carcinoma •No. of spots: 2 spots from each cancer case (70 spots) 4 non-neoplastic spots (4 spots) •Total spots: 74 •Corresponding normal tissues with cancers: Yes •Diameter: 1.0 mm Documents: •Product specification: layout, summary of tissue spots •H&E stained images •Detailed pathological information Layout: Page 2 Summary of tissue spots A204 : Liver cancer tissues - Hepatocellular carcinoma (formalin fixed) For research use only No. Sex Age KeyWord E-S grade* TNM Stage 1 1, 2 f 48 hepatocellular carcinoma I T2NxM0 (II) ...

A205 : Liver cancer tissues - Cholangiocarcinoma (formalin fixed) For research use only Specifications: •No. of cases: 46 •Tissue type: Liver cancer tissues – Chalangicarcinoma •No. of spots: 2 spots from each cancer case (92 spots) 4 non-neoplastic spots (4 spots) •Total spots: 96 •Corresponding normal tissues with cancers: No •Diameter: 1.0 mm Documents: •Product specification: layout, summary of tissue spots •H&E stained images •Detailed pathological information Layout: Page 2 Summary of tissue spot A205 : Liver cancer tissues - Cholangiocarcinoma (formalin fixed) For research use only No Sex Age KeyWord Grade TNM Stage 1 1, 2 f 73 Cholangio ca. G1 T1N0M0 (I) 2 3, 4 f 69 ...

26 COMMUNITY ONCOLOGY ¦ June 2006 www.CommunityOncology.net Manuscript received March 31, 2006; accepted April 10, 2006. Correspondence to:Nancy E.Kemeny,MD,Department of Sol- id Tumor/Gastrointestinal Oncology Service, Memorial Sloan- Kettering Cancer Center, 1275 York Avenue, Suite H916, New York, NY 10021; telephone: 212-639-8068; fax: 212-794-7186; e-mail: kemenyn@MSKCC.org. Commun Oncol 2006;3(suppl 2):26–35 © 2006 Elsevier Inc. Al rights reserved. Emerging Strategies for the Treatment of Metastatic Colorectal Cancer T he liver is the most common, and often the only, site of metastatic disease in patients with colorec- tal cancer (CRC). 1 However, only 5%–10% of all patients with CRC have metastatic disease restricted to the liver that is amenable to curative resection. 2 The usual criteria for unresectability ...

SCIENCE RADIATION ONCOLOGY 106 MEDICAL SOLUTIONS OCTOBER 2005 Siemens Imaging Solutions Facilitate New Radiation Therapy Approach to Liver Cancer Using yttrium-90 microspheres is a new intraarterial therapy that uses beta-irradiating microspheres directly delivered to the tumor. The procedure demands the use of technologically advanced imaging equipment. A case study. By Andrew S. Kennedy, M.D., FACRO, Wake Radiology Oncology, Cary, NC Most patients with colorectal, breast, lung, hepatocellular, and pancreatic cancers are at risk to recur from metastatic disease in the liver after potentially curative treatment. When the liver does harbor metastatic or primary cancer , treatment options and ultimately their chances of survival rapidly decline. That is in part because the liver is at once amazing in its ability to grow larger (hypertrophy) ...

Web Immagini Gruppi Directory News altro » Ricerca avanzata Preferenze Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL Web La ricerca di - cache:68fjzQ8MyfAJ:https://www.medical.siemens.com/siemens/en_GB/rg_marcom_FBAs/files/brochures/magazin_2_2005/P106-107_Science_Radiation_e.pdf liver cancer filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti: Assicurarsi che tutte le parole siano state digitate correttamente. Provare con parole chiave diverse. Provare con ...

447 March Road Kanata, Ontario Canada K2K 1X8 Tel: 613 592-2790 NEWS RELEASE March 21, 2000 Inoperable Primary Liver Cancer Treatment Receives Humanitarian Device Exemption TheraSphere’s Microscopic Glass Beads Offer Alternative to Chemotherapy in Inoperable Cases Kanata, Ontario, Canada - MDS Nordion, a global leader in radioisotope technology, received authorization from the US Food and Drug Administration to market TheraSphere ® , a non-surgical outpatient therapy that uses microscopic glass beads to deliver radiation therapy to treat inoperable hepatocellular carcinoma (HCC), a liver cancer . This form of liver cancer is one of the most common tumours in the world, affecting up to 10 percent of the population in sub-Saharan Africa and Southeast Asia. 1 At present, the incidence of HCC in the US is low, but is expected to increase due to a ...

1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com HUMAN LIVER CANCER TISSUE ARRAY Catalog Number: TMA-121 Each dot represents a DISEASED tissue spot from one individual specimen that was selected and pathologically confirmed ( Liver carcinoma tissue array) Cases: 63 Cores: 63 Diameter: 1.5mm Thickness: 5 µm Standard IHC: PCNA confirmed Layout : 7 x 9 1 2 3 4 5 6 7 8 9 A 1 2 3 4 5 6 7 8 9 B 10 11 12 13 14 15 16 17 18 C 19 20 21 22 23 24 25 26 27 D 28 29 30 31 32 33 34 35 36 E ...

1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com HUMAN LIVER CANCER TISSUE ARRAY Catalog Number: TMA-126 Each three (3) dots from three different tissue spots represents one single specimen that was selected and pathologically confirmed (Hepatocellular carcinoma tissue array) Cases: 22 Cores: 63 Diameter: 1.5mm Thickness: 5 µm Standard IHC: AFP confirmed Layout : 7 x 9 1 2 3 4 5 6 7 8 9 A 1 2 3 4 5 6 7 8 9 B 10 11 12 13 14 15 16 17 18 C 19 20 21 22 23 24 25 26 27 D 28 29 30 31 32 33 34 35 ...

1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com HUMAN LIVER CANCER TISSUE ARRAY Catalog Number: TMA-125 Each three (3) dots from three different tissue spots represents one single specimen that was selected and pathologically confirmed (Hepatocellular carcinoma tissue array) Cases: 21 Cores: 63 Diameter: 1.5mm Thickness: 5 µm Standard IHC: PCNA confirmed Layout : 7 x 9 1 2 3 4 5 6 7 8 9 A 1 2 3 4 5 6 7 8 9 B 10 11 12 13 14 15 16 17 18 C 19 20 21 22 23 24 25 26 27 D 28 29 30 31 32 33 34 35 ...

1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com HUMAN LIVER CANCER TISSUE ARRAY Catalog Number: TMA-123 This is a COMBINATION ARRAY PANEL from diseased, normal and adjacent (1.5cm) to specimen that was selected and pathologically confirmed ( Liver carcinoma tissue array) Cases: 42 Cores: 63 Diameter: 1.5mm Thickness: 5 µm Standard IHC: PCNA confirmed Layout : 7 x 9 1 2 3 4 5 6 7 8 9 A 1 2 3 4 5 6 7 8 9 B 10 11 12 13 14 15 16 17 18 C 19 20 21 22 23 24 25 26 27 D 28 29 30 31 32 33 34 35 ...

1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com HUMAN LIVER CANCER TISSUE ARRAY Catalog Number: TMA-122 Each dot represents a DISEASED tissue spot from one individual specimen that was selected and pathologically confirmed ( Liver carcinoma tissue array) Cases: 63 Cores: 63 Diameter: 1.5mm Thickness: 5 µm Standard IHC: PCNA confirmed Layout : 7 x 9 1 2 3 4 5 6 7 8 9 A 1 2 3 4 5 6 7 8 9 B 10 11 12 13 14 15 16 17 18 C 19 20 21 22 23 24 25 26 27 D 28 29 30 31 32 33 34 35 36 E ...

1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com HUMAN LIVER CANCER TISSUE ARRAY Catalog Number: TMA-124 Each three (3) dots from three different tissue spots represents one single specimen that was selected and pathologically confirmed (Normal liver tissue array) Cases: 20 Cores: 63 Diameter: 1.5mm Thickness: 5 µm Standard IHC: PCNA confirmed Layout : 7 x 9 1 2 3 4 5 6 7 8 9 A 1 2 3 4 5 6 7 8 9 B 10 11 12 13 14 15 16 17 18 C 19 20 21 22 23 24 25 26 27 D 28 29 30 31 32 33 34 35 36 ...

RISK FACTOR INFORMATION FOR SELECTED CANCER TYPES Source: Community Assessment Unit, Bureau of Environmental Health Assessment, Massachusetts Department of Public Health August, 2001 Liver Cancer An estimated 16,200 people in the U.S. (10,700 men and 5,500 women) will be diagnosed with liver cancer in 2001, accounting for approximately 1% of all new cancers (ACS, 2001a). Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver, accounting for about 75% of all cases. Rarer forms of malignant liver cancer include cholangiocarcinomas, angiosarcomas, and hepatoblastomas in children. Although HCC is approximately ten times more common in developing countries in East and Southeast Asia and Africa, incidence is rapidly increasing in the United States (ACS, 2001b). Rates of HCC in the U.S. have increased by 70% over the past two decades (Yu et al., 2000). Similar trends have been observed in ...

Bradfield; Mechanisms of Liver Carcinogenesis 18 UNIT V: Models of Liver Cancer, Non Genotoxic Carcinogens Assigned Reading: Pitot et al. (1996). Quantitation of multistage carcinogenesis in rat liver. Toxicologic Pathology. 24:119. 1) Not all carcinogens are genotoxic, (i.e., directly alkylate DNA and cause mutations). 2) Chemicals that enhance carcinogenic responses to genotoxic carcinogens are known as promoters. 3) Modeling HCC in rodents can be performed by monitoring the evolution of carcinogen induced enzyme altered foci. Non Genotoxic Carcinogens: Until now, we have been talking about carcinogens that act via direct/covalent modification of DNA (“alkylation”). We have talked about the early proposal that all carcinogens are mutagens. From the initial DNA alkylation studies and mutagenicity studies came the classification of mutagenic/alkylating carcinogens ...

Spring 2005 The Fight Against Hepatitis B and Liver Cancer De C al David Chao Denis Lam jrcdecal@gmail.edu http://jrc.berkeley.edu MCB 98/198, 2 Units P/NP Friday 2-3:30 pm, 220 Wheeler Course Description Hepatitis B is currently one of the top five causes of premature mortality for Asian & Pacific Islander Americans (APIA) – yet it is preventable by a vaccine which has been available for over 20 years. The Jade Ribbon Campaign DE-Cal course addresses the issues of hepatitis B and liver cancer, and their impact both here in the United States and abroad in countries such as China. After learning about the virology, biochemistry, and epidemiology of the disease, students will have an opportunity to put their new knowledge about hepatitis B into community practice in this service learning course. Through listening to guest lectures, participation ...

l del file contenuto in https://www.long-beach.med.va.gov/Our_services/Administrative_care/patientEd/documents/Liver%20Cancer.doc . G o o g l e crea automaticamente la versione .html dei documenti durante la scansione del Web. Per inserire un segnalibro o un collegamento alla pagina, utilizzare il seguente URL: http://www.google.com/search?q=cache:sAq01npArfUJ:https://www.long-beach.med.va.gov/Our_services/Administrative_care/patientEd/documents/Liver%2520Cancer.doc+liver+cancer+filetype:pdf+OR+filetype:doc+OR+filetype:ppt+OR+filetype:xls+OR+filetype:rtf&hl=it&ct=clnk&cd=71&lr=lang_en Google non è collegato agli autori di questa pagina e non è responsabile del suo contenuto. I termini specificati sono presenti solamente in collegamenti che rimandano alla seguente pagina: liver cancer 1126 LIVER CANCER A Service of the Long Beach V A M C Patient Education Series 1998 ...